Publications by authors named "P Martin Rojas-Marcos"
Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes.
Endocr Connect
August 2023
Article Synopsis
- This study looked at how common it is for people with a condition called primary aldosteronism (PA) to also have a problem with cortisol production, known as autonomous cortisol secretion (ACS).
- They found that about 29% of patients with PA had ACS, especially those who were older or had larger tumors.
- Despite some differences in age and tumor size, having ACS didn't change how well patients did after surgery or their overall health compared to those who only had PA.
Objective: The aim of this study was to evaluate the rate of adrenal venous sampling (AVS) performance in patients with primary aldosteronism (PA), the main reasons for its non-performance, and the success and complications rate of this procedure in Spain. Moreover, the concordance between CT/MRI and AVS for PA subtyping was evaluated.
Methods: A retrospective multicenter study of PA patient follow-up in 20 Spanish tertiary hospitals between 2018-2021 was performed (SPAIN-ALDO Register).
Article Synopsis
- The study aimed to analyze how the age at which patients are diagnosed with differentiated thyroid carcinoma (DTC) affects their risk of disease progression and mortality after initial treatment, focusing on patients over 60 years old.
- Researchers compared two age groups: elderly (60-74 years) and very old (75 years and older) among 1,668 patients, finding that older patients generally had larger tumors, more vascular invasion, and lower rates of lymphocytic thyroiditis.
- The results indicated that while older age correlates with lower overall survival, very old patients do not face an increased risk of structural disease compared to their younger counterparts throughout the follow-up period.
Objective: To compare the presentation and evolution of primary aldosteronism (PA) in the elderly (≥65 years) and young patients (<65 years).
Methods: A retrospective multicenter study was performed in 20 Spanish hospitals of PA patients in follow-up between 2018 and 2021.
Results: Three hundred fifty-two patients with PA <65 years and 88 patients ≥65 years were included.
Evolution of the cardiometabolic profile of primary hyperaldosteronism patients treated with adrenalectomy and with mineralocorticoid receptor antagonists: results from the SPAIN-ALDO Registry.
Endocrine
June 2022
Objective: To analyze the evolution of the cardiometabolic profile of patients with primary hyperaldosteronism (PA) after the treatment with surgery and with mineralocorticoid receptor antagonists (MRA).
Design: Retrospective multicentric study of patients with PA on follow-up in twelve Spanish centers between 2018 and 2020.
Results: 268 patients with PA treated by surgery (n = 100) or with MRA (n = 168) were included.